Clinical Trial

External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
Postoperative pain after laparoscopic major upper abdominal surgery (e.g., gastric, hepatic, gallbladder, pancreatic surgery) is often severe, and inadequate analgesia may lead to increased opioid use, opioid dependence, and poor functional recovery. Current analgesic techniques such as neuraxial block have safety concerns (e.g., hypotension, neurological injury), while transversus abdominis plane (TAP) block is ineffective for blocking the lateral cutaneous branches of intercostal nerves in the upper abdomen. The External Oblique Intercostal Plane Block (EOIB) is a novel regional block technique that has shown promise in reducing postoperative opioids and pain in small-scale studies, but evidence for its use in major upper abdominal surgery is limited. This randomized controlled trial (RCT) aims to evaluate the analgesic efficacy and safety of bilateral EOIB combined with standard multimodal analgesia versus standard multimodal analgesia alone in patients undergoing elective laparoscopic major upper abdominal surgery. The primary outcome is the total postoperative opioid consumption (measured as Morphine Milligram Equivalents, MME) within 24 hours. Secondary and additional outcomes include pain scores (Verbal Rating Scale, VRS), recovery quality (QoR-15 scale), incidence of adverse events, and hospital stay.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-05-27
notable Primary completion pushed: 2026-04-15 -> 2026-08-20 2026-05-27
minor Completion pushed: 2026-04-20 -> 2026-08-31 2026-05-27
Trial Details
NCT Number NCT07331441
Lead Sponsor Jun Zhang
Conditions Abdominal Surgery, Postoperative Pain
Enrollment 78 participants
Start Date 2026-02-01
Primary Completion 2026-08-20 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25